ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc (AMPH)

49.29
1.72
(3.62%)
Closed October 15 4:00PM
49.29
-0.02
(-0.04%)
After Hours: 6:56PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
49.29
Bid
47.62
Ask
49.88
Volume
284,225
47.63 Day's Range 49.32
36.56 52 Week Range 65.9249
Market Cap
Previous Close
47.57
Open
47.76
Last Trade Time
Financial Volume
$ 13,815,361
VWAP
48.6071
Average Volume (3m)
363,032
Shares Outstanding
48,675,822
Dividend Yield
-
PE Ratio
17.45
Earnings Per Share (EPS)
2.83
Revenue
644.4M
Net Profit
137.55M

About Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company... Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
-
Amphastar Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMPH. The last closing price for Amphastar Pharmaceuticals was $47.57. Over the last year, Amphastar Pharmaceuticals shares have traded in a share price range of $ 36.56 to $ 65.9249.

Amphastar Pharmaceuticals currently has 48,675,822 shares outstanding. The market capitalization of Amphastar Pharmaceuticals is $2.32 billion. Amphastar Pharmaceuticals has a price to earnings ratio (PE ratio) of 17.45.

AMPH Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.785.9772092023246.5149.3145.5528393746.68601669CS
40.751.5451174289248.5450.7545.532220748.02195389CS
129.3923.533834586539.950.7538.4236303245.45650683CS
269.4923.844221105539.850.7536.5636088842.96732744CS
523.477.5731121780945.8265.924936.5640426848.04745152CS
15629.92154.4656685619.3767.6618.1237996741.05580888CS
26029.51149.19110212319.7867.6612.32531647134.7226955CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.08
(184.51%)
249.54M
DRUGBright Minds Biosciences Inc
$ 2.49
(130.58%)
21.5M
INVOINVO BioScience Inc
$ 1.2246
(86.96%)
56.08M
VERBVerb Technology Company Inc
$ 12.80
(61.82%)
37.9M
RANIRani Therapeutics Holdings Inc
$ 3.18
(57.43%)
55.21M
MTEMMolecular Templates Inc
$ 0.39
(-73.47%)
7.22M
ZPTAZapata Computing Holdings Inc
$ 0.0768
(-70.57%)
44.51M
VEVVicinity Motor Corporation
$ 0.0735
(-37.23%)
8.44M
TWGTop Wealth Group Holding Ltd
$ 4.59
(-35.71%)
11.25M
VCIGVCI Global Ltd
$ 0.1034
(-23.97%)
14.46M
TVGNTevogen Bio Holdings Inc
$ 1.08
(184.51%)
249.54M
NVDANVIDIA Corporation
$ 138.07
(2.43%)
232.42M
GRTSGritstone bio Inc
$ 0.0544
(6.88%)
172.2M
SOFISoFi Technologies Inc
$ 10.04
(11.43%)
116.83M
SQQQProShares UltraPro Short QQQ
$ 6.99
(-2.51%)
113.93M

AMPH Discussion

View Posts
Gentlemen Prefer Bonds Gentlemen Prefer Bonds 2 years ago
I've bought some AMPH at $31. Great products and decent numbers. Hoping for a move back up to the low $40's.
πŸ‘οΈ0
stocktrademan stocktrademan 2 years ago
AMPH buy 42.3299

https://finance.yahoo.com/quote/AMPH/profile?p=AMPH

https://www.barchart.com/stocks/quotes/AMPH

https://finviz.com/quote.ashx?t=AMPH

https://www.stockconsultant.com/consultnow/basicplus.cgi?symbol=AMPH

https://stockcharts.com/c-sc/sc?chart=AMPH,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20][iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!lf14][j20444984,y]&r=3555b

https://www.barchart.com/etfs-funds/quotes/AMPH/technical-chart?plot=CANDLE&volume=toAMPH&data=DO&density=X&pricesOn=1&asPctChange=0&logscale=1&indicators=TREND&sym=AMPH&grid=1&height=500&studyheight=100&timeframe=2%20Months




normal chart









log chart









normal chart








log chart





πŸ‘οΈ0
Golden Cross Golden Cross 4 years ago
AMPH 50/200sma crossed here...Nice bullish sign.

πŸ‘οΈ0
atarabih atarabih 4 years ago
fda approval
πŸ‘οΈ0
MakeABuck2000 MakeABuck2000 7 years ago
Gearing up for another amazing surprise quarter of positive earnings!!! Always a nice push down just before the after earnings report POP!
πŸ‘οΈ0
mick mick 7 years ago
reading my friend, their drug helper going on shelf item, any thoughts ?????
πŸ‘οΈ0
DewDiligence DewDiligence 8 years ago
China has several generic-insulin products already on the market.
πŸ‘οΈ0
Phaeton Phaeton 8 years ago
Do you see them investing in China to develop generic insulin since China has a huge diabetes problem?
πŸ‘οΈ0
Jess070283 Jess070283 8 years ago
Squeezing up! I love it
πŸ‘οΈ0
floblu14 floblu14 8 years ago
Momenta, Sandoz allowed to broaden claims over quality test patent

A federal judge has allowed Momenta Pharmaceuticals and Sandoz Inc to broaden a lawsuit accusing Amphastar Pharmaceuticals of infringing a patent on quality control methods used in making the blood thinner enoxaparin, the generic form of French drug maker Sanofi's Lovenox.

U.S. District Judge Nathaniel Gorton in Massachusetts said Tuesday that Momenta and Sandoz could add new infringement allegations to their complaint in light of a ruling last November by the U.S. Court of Appeals for the Federal Circuit that California-based Amphastar is not protected by a safe harbor provision in the patent law.

http://www.reuters.com/article/health-patent-idUSL1N19F0C7

Ampha market cap is about 750 M and is valued way less than the damage they caused. Momenta was making about a 1 M a day on lovonox before the Ampha debacle. bp

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=123595244
πŸ‘οΈ0
DewDiligence DewDiligence 9 years ago
AMPH is not a start-up, but it has trouble making money, evidently. The past 3 quarters have basically been at break-even.
πŸ‘οΈ0
DewDiligence DewDiligence 9 years ago
Update on Lovenox patent case: #msg-113632332.
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
No issue.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
IT IS 32 MILLION FROM NOW TO END OF 2015
IT IS THE 2ND TO LAST QUESTION

will not respond again.

http://www.amphastar.com/
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
They did give a number for their MANNKIND production only that it was very profitable. Your wrong. Sorry. You need to listen again.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
You just did not hear it ....
call AMPH and you will find out they did.
If I owned stock I would call ....
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
They did not give any dollar figure for their sales to MannKind.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
This EPS info is wrong.
Sorry ....
πŸ‘οΈ0
TREND1 TREND1 10 years ago
Phaeton
Did you catch only 32 million sales to MNKD in 2015
in the conf call ?
πŸ‘οΈ0
TREND1 TREND1 10 years ago
Share buyback program for AMPH

On November 6, 2014, the Company's Board of Directors authorized a $10.0 million share buyback program, which is expected to continue for an indefinite period. The primary goal of the program is to offset dilution created by the Company's equity compensation programs.

Purchases may be made through the open market and private block transactions pursuant to Rule 10b5-1 plans, privately negotiated transactions, or other means, as determined by the Company's management and in accordance with the requirements of the Securities and Exchange Commission.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
Do you have a phone number for that call you posted ?
πŸ‘οΈ0
TREND1 TREND1 10 years ago
Phaeton
Is that what you are going to do ?
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Dump all you mannkind and buy amph.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
AMPH NOV 28, 2014

Amphastar Pharmaceuticals, Inc. (AMPH) is a specialty pharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AMPH’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Amphastar Pharmaceuticals could be a solid choice for investors.Current Quarter Estimates for AMPH In the past 30 days, 1 estimate has gone higher for Amphastar Pharmaceuticals while none has gone lower in the same time period. The trend has been pretty favorable too, with loss estimates narrowing down from 11 cents a share 30 days ago, to 6 cents today, a move of over 45.5%.Current Year Estimates for AMPH Meanwhile, Amphastar Pharmaceuticals’ current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to 1 moving lower. The loss estimate trend has also seen a boost for this time frame, narrowing down from 16 cents per share 30 days ago to 14 cents per share today, an improvement of 12.5%.Bottom Line The stock has also started to move higher lately, adding 6.5% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
πŸ‘οΈ0
TREND1 TREND1 10 years ago
AMPH 30 This chart has gotten a little ahead of it self . IMHO

πŸ‘οΈ0
TREND1 TREND1 10 years ago
AMPH M

πŸ‘οΈ0
TREND1 TREND1 10 years ago
AMPH D

πŸ‘οΈ0
Phaeton Phaeton 10 years ago
I went back and listened to the Amphstar call again. They said that they had 9 billion in the pipeline on generic products using their inhalation side of their business. They particularly stated that they were working on PARTICULE ENGINEERING of complex molecules. They view their inhalation side of the business with a higher value. That Amphstar would do the science side and that a Pharm partner would do the sales and marketing side. Makes me wonder if they are going to use the Technosphere on some generic drugs. I would encourage you go listen to the call and give your opinion. I found the call interesting. this part was in the last 7 or 8 mins of the call. One of the generics mentioned was Advir
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Piper Jaffery call this morning.

Amphstar said on their call today, That they became instantly profitable based on the deal they made to supply insulin to mannKind. I missed part of the call so I don't know if they talked earlier about that purchased by mankind but I thought it was good that it was mentioned about their profitability was based on their contract and future sales to MannKind. They also stated that they had some new drugs in their pipeline where they would be partnering with another firm. Did not mention Mannkind but the decussion was on particle molucules and peptides involving inhalation drugs. I thought it was a very interesting call. I will try and go back and listen to the 5 mins that I missed when the call is reposted.
πŸ‘οΈ0
drupac drupac 10 years ago
I'm interested due to their naloxone product- I can't figure out what was with that mid-day spike today but I'm trying to get a feeling for this one
πŸ‘οΈ0
DewDiligence DewDiligence 10 years ago
I do a little.
πŸ‘οΈ0
drupac drupac 10 years ago
Anyone been following this company?
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Go check out the Friends of MannKind board on this site.
If you want information on the partner to AMPH. Or post information regarding MNKD partnership with MNKD here on this board.

Home > Boards > Free Zone > User's Groups >
Friends of MannKInd
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Forbes on Fox just recommended buying AMPH. Funny how people like the supplier of insulin enough but not the producer of Afrezza.
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
good posting on AMPHASTAR partner.
Moved from the MNKD Board.

Ha Ha Ha we are trying to be a POS penny stock like the ones you follow. Perhaps our bad Karma will get us to that position. But I am betting that won't happen. Perhaps today its ugly but let's see where we are this time next year.

A good Doctor had these comments on another message board. Perhaps he see's the future of Diabetic treatment.

Let me give you the perspective of a primary care physician. Sanofi tried for a long time to push Apidra to us. There was not enough of a difference between it and our standards, Novolog and Humalog, to convince many to change, so the sales with primary care docs fell flat. As a result Sanofi now positions Apidra as the preferred insulin for pumps and they have been somewhat successful with that marketing strategy. Afrezza on the other hand is a totally different product. It is inhaled, not just another shot. And it does not come with a complicated delivery device like Exubera did. Have you ever seen the delivery device for Exubera? It was extremely complicated. Despite being instructed in its use on several occasions I could see that it was far too complicated for the average patient and therefore never prescribed Exubera. The Dreamboat on the other hand is extremely simple and requires less instruction time than even the simplest of the insulin pens. And yes, I have actually had a Dreamboat in my hands so I know what I am talking about. This will save me time in my office, something that is going away quickly as the practice of medicine becomes more and more complex thanks to all the regulations from Uncle Sam and the other insurance companies. The reason that Exubera failed was the delivery device first of all and the fact that it was in milligrams, not units (and the mg to unit conversion was not even 1:1, too complicated). All a patient has to do with the Dreamboat is open it up, insert a cartridge, close it, and breathe in deeply. And every 2 weeks just drop the used Dreamboat in a trash can and pull out a fresh clean Dreamboat. No cleaning, no replacing parts, etc, etc, etc that were required with the Exubera bong. And it will fit in the pocket of any man, something that a man could actually do with the Exubera device but resulted in him getting all sorts of crude comments from those around him.
For those of you who think for whatever reason that Afrezza will fail you should think again. I have been doing this a long, long time. This is going to be a game changer. In diabetes for now. But in many medical fields in the coming years. I am not pumping as you call it on this board, I am simply looking at what goes on in an average primary care practice. I am sure that there will be criticisms of this post. That seems to occur for most posts that look at the good side of Afrezza. Bring it on. And mark my word. And mark this post. (Last 2 sentences thrown in on purpose to raise the hair on the back of the necks of those who get all upset when they read those words.)

I look forward to my investment returning me a a great increase in PPS and the game changer it brings to the Diabetic community. So if MannKind is not at $15.00 this time next year its a failure. If the company is not purchased by SNY for $30.00 per share next year its a failure. But at least I have enjoyed the fact that long term this product will benefit Millions of diabetics in the USA and the world. Mark my word.

Mannkind is not a plane crash.
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Yep be we will be rising soon on MNKD. Should have bought this at 9.00 instead of buying more of MannKind. But I bet we all will be ok. In DC wed - Sunday. Up for coffee in sat or Sunday
πŸ‘οΈ0
KingDMC KingDMC 10 years ago
Silent riser I love it!
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Only what is know publicly. MannKind will be buying a lot of insulin which will be sold by Sanofi.
πŸ‘οΈ0
fatcat2 fatcat2 10 years ago
Can you go into more detail about the "Mannkind contract" that you mentioned?
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Should have reseved some extra cash for AMPH. Seems to be moving in the right direction. You have to think that most of it is because of the MannKind contract.
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Definitely a good stock to keep an eye on With it's ties to mannkind this will be a winner
πŸ‘οΈ0
stocktrademan stocktrademan 10 years ago
$AMPH DD Notes ~ http://www.ddnotesmaker.com/AMPH

bullish

$AMPH recent news/filings

## source: finance.yahoo.com

Tue, 26 Aug 2014 10:55:03 GMT ~ Increased Earnings Estimates Seen for Amphaster Pharmaceuticals (AMPH): Can It Move Higher?


read full: http://finance.yahoo.com/news/increased-earnings-estimates-seen-amphaster-105503341.html
*********************************************************

Mon, 25 Aug 2014 10:37:10 GMT ~ Why Amphastar Pharmaceuticals (AMPH) Stock Might be a Great Pick


read full: http://finance.yahoo.com/news/why-amphastar-pharmaceuticals-amph-stock-103710002.html
*********************************************************

Wed, 13 Aug 2014 20:17:38 GMT ~ AMPHASTAR PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report


read full: http://biz.yahoo.com/e/140813/amph10-q.html
*********************************************************

Tue, 12 Aug 2014 20:17:56 GMT ~ Amphastar Pharmaceuticals Reports Revenues of $49.0 Million for the Second Quarter Ended June 30, 2014

[at noodls] - Previous Release RANCHO CUCAMONGA, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (Nasdaq:AMPH) ("Amphastar" or the "Company") today reported results for ...

read full: http://www.noodls.com/view/95D663AB3AE09C53FF0E0DB8C7D9D337DA11E846
*********************************************************

Tue, 12 Aug 2014 20:02:10 GMT ~ AMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen


read full: http://biz.yahoo.com/e/140812/amph8-k.html
*********************************************************


$AMPH charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$AMPH company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/AMPH/company-info
Ticker: $AMPH
OTC Market Place: Not Available
CIK code: not found
Company name: Amphastar Pharmaceuticals, Inc.
Incorporated In: USA


$AMPH share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AMPH extra dd links

Company name: Amphastar Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AMPH+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AMPH+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AMPH+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/news - http://finance.yahoo.com/q/h?s=AMPH+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AMPH/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AMPH+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AMPH
DTCC (dtcc.com): http://search2.dtcc.com/?q=Amphastar+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Amphastar+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Amphastar+Pharmaceuticals%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AMPH
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AMPH&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AMPH
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AMPH+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AMPH+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AMPH
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AMPH
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AMPH+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AMPH/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AMPH+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AMPH.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AMPH
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AMPH/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AMPH/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AMPH
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AMPH
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AMPH:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AMPH
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AMPH



$AMPH DD Notes ~ http://www.ddnotesmaker.com/AMPH
πŸ‘οΈ0
DewDiligence DewDiligence 10 years ago
Five directors recently made small open-market purchases: #msg-105505991.
πŸ‘οΈ0
KingDMC KingDMC 10 years ago
With SNY and MNKD news, this should bring AMPH up as well I assume.
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
Don't be crashing my F-15.

We need to be flying high
πŸ‘οΈ0
Skitradr Skitradr 10 years ago
There is some interesting developments here as for sure
πŸ‘οΈ0
Skitradr Skitradr 10 years ago
Were you able to read the info?
πŸ‘οΈ0
Skitradr Skitradr 10 years ago
Can't pull up info without a membership
πŸ‘οΈ0
Phaeton Phaeton 10 years ago
http://www.sec.gov/edgar/searchedgar/ctorders.htm#.U-ZxTWK9KSN

http://secfilings.nasdaq.com/filingFrameset.asp?CoName=AMPHASTAR+PHARMACEUTICALS%2C+INC%2E&eHTML=&FileName=9999999997%2D14%2D011414%2Etxt&FilePath=%5C2014%5C06%5C25%5C&FormType=CT+ORDER&Market=&RcvdDate=6%2F25%2F2014&site=&sitesubtype=&Ticker=&View=html
πŸ‘οΈ0
Skitradr Skitradr 10 years ago
Don't see how one could go wrong with this.......
Chart looks good also...
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock